Skip to main content
13 August 2026
10 February 2026

BD Separates Biosciences Unit, Completes Strategic Combination with Waters

 BD announced the successful completion of the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business and the combination of the business with Waters Corporation .  In connection with the transaction, BD shareholders will receive approximately 0.135 shares of Waters common stock for eac…

10 February 2026

Azenta Partners Frontier Space for Life Sciences Research in Microgravity

Azenta, Inc. announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space. This collaboration aims to harness the unique benefits of the microgravity environment to accelerate discovery and innovation in life scienc…

09 February 2026

Cellares Builds European Manufacturing Footprint with New Leiden Facility

Cellares, the first Integrated Development and Manufacturing Organizatio, announced it has secured a site and signed a long-term lease for a new IDMO Smart Factory at Leiden Bio Science Park (LBSP) with Dura Vermeer Commercieel Vastgoed. The facility will serve as Cellares’ European headquarters and expand the company…

09 February 2026

Nanologica Strengthens Manufacturing Footprint with Södertälje Acquisition

Nanologica AB has entered into an agreement and completed the acquisition of all shares in Ardena Södertälje AB (“Syntagon”) from Ardena Sweden. The purchase price amounts to approximately SEK 8.6 million and will be paid in the form of newly issued shares in Nanologica. Syntagon is a Contract Development and Manufact…

09 February 2026

Innovent–Lilly Pact Strengthens Global Development of Innovative Biologics

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Compa…

06 February 2026

OXB Expands Strategic Partnership with Bristol Myers Squibb for CAR-T Manufacturing

OXB , a global quality and innovation-led cell and gene therapy CDMO, announces it has expanded its strategic partnership with Bristol Myers Squibb , signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS' CAR-T programmes. This expanded partnership builds on the …

05 February 2026

Jumo Health Partners with Areti Health to Power AI-Driven Trial Readiness Platform

Jumo Health, a Patient Experience Organization, today announced a strategic partnership with Areti Health, an AI technology company, to advance the innovation and execution of PRISM™, Jumo Health's readiness-based clinical trial recruitment, enrollment, and retention system. PRISM was created to address a persistent …

03 February 2026

SanegeneBio, Genentech Partner on RNAi Therapeutics Development

SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced a global licensing agreement with Genentech, a member of the Roche Group, to advance one of its RNAi programs based on its proprietary RNAi platform. Under the agreement, SanegeneBio grants Genentech exclusive worldw…

02 February 2026

SomaLogic Acquisition Advances Illumina’s Drug Discovery Push

Illumina, Inc. announced that it has completed its acquisition of SomaLogic, a leader in data-driven proteomics technology. The highly complementary proteomics capabilities expand Illumina's multiomics portfolio, strengthening customer access to proteomic insights at scale to help drive faster drug discovery and posit…

Page 16 of 36